Screening of Kozak-motif-located SNPs and analysis of their association with human diseases

Biochemical and Biophysical Research Communications

Volumn 392, Issue 1, 2010, Pages 89-94

  Xu, Heng ^a   Wang, Ping ^a   You, Jin ^a   Zheng, Yufang ^c   Fu, Yujie ^a   Tang, Quan ^a   Zhou, Li ^a   Wei, Zejun ^a   Lin, Bin ^a   Shu, Yang ^a   Zhu, Yufei ^a   Hu, Landian ^a,b   Kong, Xiangyin ^a,b  

^a SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Disease; Kozak motif; Single nucleotide polymorphism; Start codon; Translation

Indexed keywords

ARTICLE; BIOINFORMATICS; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INTRON; PRIORITY JOURNAL; PROTEIN MOTIF; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; START CODON; WESTERN BLOTTING;

CODON, INITIATOR; DISEASE; DNA MUTATIONAL ANALYSIS; EXONS; HAPLOTYPES; HUMANS; INTRONS; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 75049086086     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.01.002     Document Type: Article

References (24)

1. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell Biol. 115 (1991) 887-903
2. Kozak M. Context effects and inefficient initiation at non-AUG codons in eucaryotic cell-free translation systems. Mol. Cell Biol. 9 (1989) 5073-5080
3. Kozak M. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. Embo J. 16 (1997) 2482-2492
4. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44 (1986) 283-292
5. Kozak M. Emerging links between initiation of translation and human diseases. Mamm. Genome 13 (2002) 401-410
6. Tomer Y., Concepcion E., and Greenberg D.A. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12 (2002) 1129-1135
7. Jacobson E.M., Concepcion E., Oashi T., and Tomer Y. A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146 (2005) 2684-2691
8. Maguire J.M., Thakkinstian A., Sturm J., et al. Polymorphisms in platelet glycoprotein 1balpha and factor VII and risk of ischemic stroke: a meta-analysis. Stroke 39 (2008) 1710-1716
9. Baker R.I., Eikelboom J., Lofthouse E., et al. Platelet glycoprotein 1balpha Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 98 (2001) 36-40
10. Ozturk A., DeKosky S.T., and Kamboh M.I. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease. Neurobiol. Aging 27 (2006) 1440-1444
11. Osgood D., Corella D., Demissie S., et al. Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the framingham study. J. Clin. Endocrinol. Metab. 88 (2003) 2869-2879
12. Wu X., Ye Y., Kiemeney L.A., et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat. Genet. (2009)
13. Sakamoto H., Yoshimura K., Saeki N., et al. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat. Genet. 40 (2008) 730-740
14. Manolio T.A., Brooks L.D., and Collins F.S. A HapMap harvest of insights into the genetics of common disease. J. Clin. Invest. 118 (2008) 1590-1605
15. Fisher E., Nitz I., Gieger C., et al. Association of acyl-CoA-binding protein (ACBP) single nucleotide polymorphisms and type 2 diabetes in two German study populations. Mol. Nutr. Food Res. 51 (2007) 178-184
16. Fisher E., Nitz I., Lindner I., et al. Candidate gene association study of type 2 diabetes in a nested case-control study of the EPIC-Potsdam cohort-role of fat assimilation. Mol. Nutr. Food Res. 51 (2007) 185-191
17. Thoeringer C.K., Binder E.B., Salyakina D., et al. Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks. J. Psychiatr. Res. 41 (2007) 579-584
18. Shi J., Misso N.L., Kedda M.A., et al. Cyclooxygenase-2 gene polymorphisms in an Australian population: association of the -1195G>A promoter polymorphism with mild asthma. Clin. Exp. Allergy 38 (2008) 913-920
19. Corella D., Gonzalez J.I., Bullo M., et al. Polymorphisms cyclooxygenase-2-765G>C and interleukin-6-174G>C are associated with serum inflammation markers in a high cardiovascular risk population and do not modify the response to a Mediterranean diet supplemented with virgin olive oil or nuts. J. Nutr. 139 (2009) 128-134
20. Sitarz R., Leguit R.J., de Leng W.W., et al. The COX-2 promoter polymorphism -765G>C is associated with early-onset conventional and stump gastric cancers. Mod. Pathol. 21 (2008) 685-690
21. Talmud P.J., Palmen J., Putt W., et al. Determination of the functionality of common APOA5 polymorphisms. J. Biol. Chem. 280 (2005) 28215-28220
22. Sudakov S.K., Medvedeva O.F., Rusakova I.V., et al. Differences in genetic predisposition to high anxiety in two inbred rat strains: role of substance P, diazepam binding inhibitor fragment and neuropeptide Y. Psychopharmacology (Berl) 154 (2001) 327-335
23. Zhang X., Liu D., Lv S., Wang H., et al. CDK5RAP2 is required for spindle checkpoint function. Cell Cycle 8 (2009) 1206-1216
24. Hughes A.E., Orr N., Esfandiary H., Diaz-Torres M., Goodship T., and Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet. 38 (2006) 1173-1177